Staphylococcus aureus - NRS1
Other designations ( Mu50; ATCC 700699 )
|
|
|
| Demographic Information: |
|
| Country/State: |
Japan |
Date of Isolation: |
05/01/1996 |
| Patient Age: |
4 Month(s) |
Gender: |
Male |
| Patient Location: |
Inpatient |
Patient Service: |
Cardiothoracic surgery |
| Culture Source: |
Wound |
|
| Phenotypic Properties: |
Resistant to aminoglycosides and tetracycline (minocycline)
|
|
| Genotypic Properties: |
N/A
|
|
|
| Literature Citation: |
Hiramatsu, K., et al. 1997. Journal of
Antimicrobial Chemotherapy 40:135-136.
|
|
| Comment: |
N/A
|
| |
| Description: |
Vancomycin-intermediate strain isolated in 1996; whole genome sequenced at Juntendo University, Japan
|
|
| Repositories: |
Glycopeptide Intermediate Staphylococci
Antibiotic Resistant Strains (other than Glycopeptide)
Genome Sequenced Strains
|
|
|
|
S = Susceptible; R = Resistant; NS = Not Susceptible; I =Intermediate; N/A = Not Available P= Pending results |
|
|
NARSA Antimicrobial Profile for Other Antimicrobial Agents
|
|
Molecular Characterization Data
|
|
| Ciprofloxacin |
= 16 |
R |
| Gentamicin |
> 16 |
R |
| Oxacillin |
> 32 |
R |
| Penicillin |
> 8 |
R |
| Quinupristin/dalfopristin |
= 0.12 |
S |
| Teicoplanin |
= 8 |
S |
| Tetracycline |
= 32 |
R |
| Trimeth/sulfa |
<= 0.12/2.28 |
S |
| Vancomycin |
= 8 |
I |
|
|
|
|
|
|
|
|
